Retatrutide has not received Health Canada approval and remains in Phase 3 clinical trials globally
83 Interestingly, EX-QW appears not to have a significant additive effect
This approach of targeting the entire MC4R pathway , rather than the MC4R gene alone, enables a more viable commercial model by consolidating multiple ultra-rare diseases into a single development program
Interaction Considerations No documented direct interactions exist between Retatrutide and the healing peptides discussed
It acts as an agonist at GLP-1, GIP, and glucagon receptors to suppress appetite, delay gastric emptying, promote insulin release, and break down fats
Best options: Yogurt Kefir Sauerkraut Kimchi Miso Tempeh Dark chocolate Dark chocolate (at least 70% cacao solids) is rich in flavanols, an antioxidant that may support GLP-1 activity